From January 1st, 2014, new prices for Chr. Hansen coagulants will be implemented.
Prices will increase by 1.5-3% (depending on product group) to reflect cost increase of energy, labor and raw materials.
Chr. Hansen coagulants include products like CHY-MAX® M, CHY-MAX®, HANNILASE®, THERMOLASE®, NATUREN® and others.
These price changes will affect all coagulants, in all regions and areas, with the exception of existing contracts which will be carried out at the contract price.
If you have any questions, please contact your Chr. Hansen sales representative.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.